Found: 9
Select item for more details and to access through your institution.
Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial.
- Published in:
- Diabetic Medicine, 2008, v. 25, n. 4, p. 435, doi. 10.1111/j.1464-5491.2008.02391.x
- By:
- Publication type:
- Article
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 6, p. 2781, doi. 10.1210/jc.2009-2272
- By:
- Publication type:
- Article
Etiology and epidemiological analysis of glaucoma-filtering bleb infections in a tertiary eye care hospital in South India.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Etiology and epidemiological analysis of glaucoma-fi ltering bleb infections in a tertiary eye care hospital in south India.
- Published in:
- Indian Journal of Ophthalmology, 2011, v. 59, n. 6, p. 445, doi. 10.4103/0301-4738.86311
- By:
- Publication type:
- Article
The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2023, v. 27, n. 8, p. 3699
- By:
- Publication type:
- Article
Zebrafish Genomic Instability Mutants and Cancer Susceptibility.
- Published in:
- Genetics, 2006, v. 174, n. 2, p. 585, doi. 10.1534/genetics.106.059386
- By:
- Publication type:
- Article
POTENTIAL DRUGS AGAINST MULTIDRUG RESISTANT BACTERIA FROM OCIMUM TENUIFLORUM: AN IN SILICO ANALYSIS.
- Published in:
- New Armenian Medical Journal, 2022, v. 16, n. 3, p. 49, doi. 10.56936/18290825-2022.16.3-49
- By:
- Publication type:
- Article
Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article